Emprego da Lâmina de Imunofluorescência na ... - NewsLab
Emprego da Lâmina de Imunofluorescência na ... - NewsLab
Emprego da Lâmina de Imunofluorescência na ... - NewsLab
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
15. Mahoney MC, Nasca PC, Burnett WS, Melius JM. Bone Cancer Inci<strong>de</strong>nce Rates in New York State: Time Trends and Fluori<strong>da</strong>ted<br />
Drinking Water. American Jour<strong>na</strong>l of Public Health, Washington, 81(4): 475-479, abr. 1991.<br />
16. Tortaja<strong>da</strong> JF, Tomero OB, Garcia JAO, Morales LC, Castell JC, Perales VM, Casas LM. Factores <strong>de</strong> Riesgo para los Tumores<br />
Óseos Malignos Pediátricos. A<strong>na</strong>les <strong>de</strong> Pediatria, Barcelo<strong>na</strong>, 63(6): 537-547, <strong>de</strong>z. 2005.<br />
17. Mirra AP, Veneziano DB, Latorre MRDO. Incidência, Mortali<strong>da</strong><strong>de</strong> e Sobrevi<strong>da</strong> do Câncer <strong>da</strong> Infância no Município <strong>de</strong> São<br />
Paulo, 2001. Disponível em: .<br />
Acesso em: 20.ago.2006.<br />
18. David A, Rios AR, Tarrago RP, Otharan ER, Da Motta LQ, Almei<strong>da</strong> SG. Osteossarcoma: Revisão <strong>de</strong> 39 casos. Revista Brasileira<br />
<strong>de</strong> Ortopedia, Rio <strong>de</strong> Janeiro, 33(1): 45-48, jan. 1998.<br />
19. Ji J, Hemminki K. Inci<strong>de</strong>nce of Multiple Primary Malig<strong>na</strong>ncies Among Patients with Bone Cancer in Swe<strong>de</strong>n. Jour<strong>na</strong>l of Cancer<br />
Research and Clinical Oncology, Berlim / Hei<strong>de</strong>lberg, 132(8): 529-535, 17 mai. 2006.<br />
20. Matos MA, Pimentel N, Leite AA. Significado Prognóstico do Tamanho Tumoral no Osteossarcoma Infantil. Acta Ortopédica<br />
Brasileira, São Paulo, 10(3). jul/ago/set. 2002.<br />
21. Lima JJG, Manzi FR, Da Silva FL, Baptista M Z. Osteossarcoma Extra-Esquelético <strong>na</strong> Região Cervical – Revisão <strong>da</strong> Literatura<br />
e Relato <strong>de</strong> Caso Clínico. Radiologia Brasileira, São Paulo, 35(5): 315-319, set/out. 2002.<br />
22. Cassone AE, Picci P, Campa<strong>na</strong>cci M. Recidiva Local em Osteossarcoma. Revista Brasileira <strong>de</strong> Ortopedia, Rio <strong>de</strong> Janeiro, 32(11):<br />
882-886, nov. 1997.<br />
23. Bridge JA, Nelson M, McComb E, McGuire MH, Rosenthal H, Vergara G, Maale GE, Spanier S, Neff JR. Cytogenetic Findings<br />
in 73 Osteosarcoma Specimens and a Review of The Literature. Cancer Genetics and Cytogenetics, New York, 95(1): 74-87,<br />
mai. 1995.<br />
24. Boehm AK, Squire JA, Bayani J, Nelson M, Bridge JA. Cytogenetic Findings in 36 Osteosarcoma Specimens and a Review of<br />
The Literature.<br />
25. Pediatric Pathology Molecular Medicine, Tucson, 5: 359-376, set. 2000.<br />
26. Kirpensteijn J, Kik M, Rutteman GR, Teske E. Prognostic Significance of a New Histologic Grading System for Canine Osteosarcoma.<br />
Veteri<strong>na</strong>ry Pathology, Lawrence, 39(2): 240-246, mar. 2002.<br />
27. Simon R. Clinical Prognostic Factors in Osteosarcoma. Cancer Treat Report. 62: 193-197, 1978.<br />
28. Spanier SS, Schuster JJ, Griend RAV. The Effect of Local Extent of the Tumor on Prognosis in Osteosarcoma. The Jour<strong>na</strong>l of<br />
bone and joint surgery. American volume, Boston, 72(5): 643-653, 1990.<br />
29. Aksnes LH, Hall KS, Folleraas G, Stenwig AE, Bjerkehagen B, Taks<strong>da</strong>l I, Win<strong>de</strong>ren M, Bruland OS, Saeter G. Ma<strong>na</strong>gement of<br />
High-Gra<strong>de</strong> Bone Sarcomas Over Two Deca<strong>de</strong>s: the Norwegian Radium Hospital Experience. Acta Oncologica, Basingstoke,<br />
45(1): 38-46, fev. 2006.<br />
30. Moon SH, Shin KH, Suh JS, Yang WI, Noh JK, Hahn SB. Tumor Volume Change After Chemotheraphy as a Predictive Factor of<br />
Disease Free Survival for Osteosarcoma. Yonsei Medical Jour<strong>na</strong>l, Seul, 46(1): 119-124, fev. 2005.<br />
31. Ilic´ I, Manojlovic S, Cepulic M, Orlic D, Seiwerth S. Osteosarcoma and Ewing’s Sarcoma in Children and Adolescents: Retrospective<br />
Clinicopathological Study. Croatian Medical Jour<strong>na</strong>l, Zagreb, 45(6): 740-745, <strong>de</strong>z. 2004.<br />
32. Weichselbaum RR, Becket M, Diamond A. Some retinoblastomas, osteosarcomas, and Soft Tissue Sarcomas May Share a<br />
Common Etiology. Proceedings of The Natio<strong>na</strong>l Aca<strong>de</strong>my of Sciences of The United States of America, Washington, 85(7):<br />
2106-2109, abr. 1988.<br />
33. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, Friend SH. p53 Functions<br />
as a Cell Cycle Control Protein in Osteosarcomas. Molecular and Cellular Biology, Washington, 10(11): 5772-5781, nov. 1990.<br />
34. David JP, Mehic D, Bakiri L, Schilling AF, Mandic V, Priemel M, I<strong>da</strong>rraga MH, Reschke MO, Hoffmann O, Amling M, Wagner<br />
EF. Essential Role of RSK2 in c-Fos-Depen<strong>de</strong>nt Osteosarcoma Development. The Jour<strong>na</strong>l of Clinical Investigation, New York,<br />
115(3): 664-672, mar. 2005.<br />
130<br />
<strong>NewsLab</strong> - edição 91 - 2008
Change language